These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36636586)

  • 21. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency in Cardiolipin Reduces Doxorubicin-Induced Oxidative Stress and Mitochondrial Damage in Human B-Lymphocytes.
    Aryal B; Rao VA
    PLoS One; 2016; 11(7):e0158376. PubMed ID: 27434059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of mitochondrial cardiolipin in heart function and its implication in cardiac disease.
    Dudek J; Hartmann M; Rehling P
    Biochim Biophys Acta Mol Basis Dis; 2019 Apr; 1865(4):810-821. PubMed ID: 30837070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis.
    Grosser JA; Fehrman RL; Keefe D; Redmon M; Nickells RW
    BMC Res Notes; 2021 May; 14(1):198. PubMed ID: 34022923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice.
    Zuo Y; Yin L; Cheng X; Li J; Wu H; Liu X; Gu E; Wu J
    Front Cell Neurosci; 2020; 14():251. PubMed ID: 32903868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biallelic variants in
    Thompson K; Bianchi L; Rastelli F; Piron-Prunier F; Ayciriex S; Besmond C; Hubert L; Barth M; Barbosa IA; Deshpande C; Chitre M; Mehta SG; Wever EJM; Marcorelles P; Donkervoort S; Saade D; Bönnemann CG; Chao KR; Cai C; Iannaccone ST; Dean AF; McFarland R; Vaz FM; Delahodde A; Taylor RW; Rötig A
    HGG Adv; 2022 Apr; 3(2):100097. PubMed ID: 35321494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elamipretide as a potential candidate for relieving cryodamage to human spermatozoa during cryopreservation.
    Bai H; Zhang Y; Tian S; Hu R; Liang Y; Gao J; Wang Y; Wu B
    Cryobiology; 2020 Aug; 95():138-142. PubMed ID: 32240641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.
    Daubert MA; Yow E; Dunn G; Marchev S; Barnhart H; Douglas PS; O'Connor C; Goldstein S; Udelson JE; Sabbah HN
    Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29217757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
    Allingham MJ; Mettu PS; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
    Zhao W; Xu Z; Cao J; Fu Q; Wu Y; Zhang X; Long Y; Zhang X; Yang Y; Li Y; Mi W
    J Neuroinflammation; 2019 Nov; 16(1):230. PubMed ID: 31747905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Protection Partly Mitigates Kidney Cellular Senescence in Swine Atherosclerotic Renal Artery Stenosis.
    Kim SR; Eirin A; Zhang X; Lerman A; Lerman LO
    Cell Physiol Biochem; 2019; 52(3):617-632. PubMed ID: 30907989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome.
    Vreken P; Valianpour F; Nijtmans LG; Grivell LA; Plecko B; Wanders RJ; Barth PG
    Biochem Biophys Res Commun; 2000 Dec; 279(2):378-82. PubMed ID: 11118295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
    Ikon N; Ryan RO
    Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechano-energetic aspects of Barth syndrome.
    Dudek J; Maack C
    J Inherit Metab Dis; 2022 Jan; 45(1):82-98. PubMed ID: 34423473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
    Zegallai HM; Hatch GM
    Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial dysfunctions in barth syndrome.
    Ghosh S; Iadarola DM; Ball WB; Gohil VM
    IUBMB Life; 2019 Jul; 71(7):791-801. PubMed ID: 30746873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barth syndrome, a human disorder of cardiolipin metabolism.
    Schlame M; Ren M
    FEBS Lett; 2006 Oct; 580(23):5450-5. PubMed ID: 16973164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elamipretide Improves Mitochondrial Function in the Failing Human Heart.
    Chatfield KC; Sparagna GC; Chau S; Phillips EK; Ambardekar AV; Aftab M; Mitchell MB; Sucharov CC; Miyamoto SD; Stauffer BL
    JACC Basic Transl Sci; 2019 Apr; 4(2):147-157. PubMed ID: 31061916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental models of Barth syndrome.
    Pu WT
    J Inherit Metab Dis; 2022 Jan; 45(1):72-81. PubMed ID: 34370877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.